E

    EHAB (EHAB)

    Official site

    MEDICAL CARE FACILITIES

    $13.80
    +0.01 (+0.07%)

    Last updated: May 14, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(8/16)
    Avg Surprise
    +8.41%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$0.18
    Range$0.16 - $0.20
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.12-30.8%
    60d ago$0.16-12.9%
    30d ago$0.16-12.9%
    7d ago$0.15-16.7%
    Current$0.18
    Revenue Consensus
    $275M
    Range$270M - $281M
    5 analysts
    Period ending Sep 30, 2026
    EPS Consensus$0.20
    Range$0.17 - $0.22
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$0.15-23.0%
    60d ago$0.15-21.4%
    30d ago$0.15-21.4%
    7d ago$0.15-21.8%
    Current$0.20
    Revenue Consensus
    $279M
    Range$275M - $286M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.19---
    Sep 26EST
    		-$0.20---
    Jun 26EST
    		-$0.18---
    Mar 26
    Reported May 13
    		$0.17$0.12+36.75%Beat+66.7%
    Dec 25
    Reported Mar 4
    		$0.14$0.15-8.44%Miss+250.0%
    Sep 25
    Reported Nov 5
    		$0.17$0.12+41.67%Beat+466.7%
    Jun 25
    Reported Aug 6
    		$0.10$0.10+0.00%Beat+42.9%
    Mar 25
    Reported May 7
    		$0.10$0.06+60.26%Beat+42.9%
    Dec 24
    Reported Mar 5
    		$0.04$0.05-27.14%Miss-33.3%
    Sep 24
    Reported Nov 6
    		$0.03$0.04-25.00%Miss+0.0%
    Jun 24
    Reported Aug 6
    		$0.07$0.05+40.00%Beat+75.0%
    Mar 24
    Reported May 8
    		$0.07$0.04+75.00%Beat-22.2%
    Dec 23
    Reported Mar 6
    		$0.06$0.03+100.00%Beat-81.3%
    Sep 23
    Reported Nov 7
    		$0.03$0.06-50.00%Miss-84.2%
    Jun 23
    Reported Aug 9
    		$0.04N/A-71.43%Miss-91.5%
    Mar 23
    Reported May 9
    		$0.09$0.15-40.00%Miss-84.2%
    Dec 22
    Reported Feb 14
    		$0.32$0.23+39.13%Beat-
    Sep 22
    Reported Nov 1
    		$0.19$0.28-32.14%Miss-
    Jun 22
    Reported Aug 1
    		$0.47$0.49-4.08%Miss-
    Mar 22
    Reported Jun 21
    		$0.57$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$13.77
    SMA 20$13.75
    SMA 50$13.76
    SMA 200$10.26
    EMA 10$13.78
    EMA 20$13.77
    EMA 50$13.43
    EMA 200$11.16

    MACD

    Line: 0.03Signal: 0.04Hist: -0.01

    ADX

    ADX: 28.3+DI: 28.4-DI: 15.1

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down24.0
    PSAR$14.04

    Bollinger Bands

    Upper Band$13.80
    Lower Band$13.70
    %B Position74%(Middle)
    Band Width0.95

    RSI (14-Day)

    Neutral
    61.7

    Momentum Oscillators

    Stoch %K84.7
    Stoch %D82.9
    Williams %R-12.5
    ROC (10d)0.4%
    Momentum0.06
    CCI (20d)132.7
    MFI (14d)84.7

    Volatility Measures

    ATR (14d)$0.04(0.3%)
    StdDev (20d)0.03
    Hist Vol1.2%(Low)

    Volume Flow

    VWAP$13.80
    OBV41.8M
    AD Line9.4M
    CMF (20d)-0.212

    Volume Metrics

    Avg Vol (20d)1.0M
    Vol Ratio1.3x
    VWMA (20d)$13.77

    Pivot Points

    R3$13.83
    R2$13.82
    R1$13.80
    Pivot Point$13.79
    S1$13.78
    S2$13.77
    S3$13.75

    Advanced Oscillators

    TSI16.92
    Ultimate Osc40.7
    KST-1.87

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$264.80M$270.40M$263.60M$266.10M$259.90M$258.20M$253.60M$260.60M$262.40M$260.60M$258.30M$262.30M
    Cost of Revenue$134.20M$138.70M$135.80M$135.50M$130.20M$133.10M$131.70M$131.80M$134.20M$133.50M$134.00M$135.50M
    Gross Profit$130.60M$131.70M$127.80M$130.60M$129.70M$125.10M$121.90M$128.80M$128.20M$127.10M$124.30M$126.80M
    Operating Expenses$101.30M$165.00M$111.00M$113.90M$113.80M$166.30M$219.90M$117.60M$115.30M$122.20M$116.50M$201.30M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$96.70M$112.30M$105.50M$108.20M$107.50M$104.60M$103.80M$110.00M$107.50M$114.50M$108.80M$107.80M
    Operating Income$29.30M$-33,300,000$16.80M$16.70M$15.90M$-41,200,000$-98,000,000$11.20M$12.90M$4.90M$7.80M$-74,500,000
    Interest Income$3.80M$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$10.00M$7.60M$8.30M$8.70M$9.40M$10.10M$10.80M$10.90M$11.10M$12.30M$10.90M$10.30M
    Income Before Tax$23.00M$-40,800,000$8.40M$8.00M$25.80M$-51,300,000$-108,800,000$300,000$1.80M$-7,400,000$-3,000,000$-84,700,000
    Income Tax Expense$3.10M$-2,500,000$-3,200,000$2.30M$7.40M$-5,500,000$700,000$-100,000$900,000$-1,500,000$-800,000$-10,600,000
    Net Income$19.90M$-38,300,000$11.60M$5.70M$18.40M$-45,800,000$-109,500,000$400,000$900,000$-5,900,000$-2,200,000$-74,100,000
    EBITDA$36.10M$-28,000,000$22.60M$22.70M$41.90M$-32,900,000$-89,400,000$19.10M$21.10M$13.70M$16.10M$-66,500,000
    EBIT$29.20M$-33,400,000$16.70M$16.70M$35.20M$-41,200,000$-98,000,000$11.20M$12.90M$4.90M$7.90M$-74,400,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about EHAB

    News

    5 Top Execs to Depart Enhabit in Wake of Kinderhook Acquisition

    Five of Enhabit Inc.'s six top executive leaders are departing two months after the company's acquisition by Kinderhook Industries, with newly appointed CEO Dale Clift remaining. The departing executives, including the CFO and EVPs of Home Health and Hospice, are exercising rights under a change-in-control benefits plan established before the $1.1 billion acquisition. Enhabit, under its new CEO who previously led other Kinderhook companies, plans aggressive expansion in its home health and hospice services across 34 states.

    Hospice News•7/16/26•
    Somewhat-Bearish

    Enterprise value to revenue forward of Enhabit, Inc – GETTEX:X34

    This article provides the enterprise value to revenue forward for Enhabit, Inc, traded on GETTEX under the symbol X34. It appears to be a financial data point from TradingView, which offers various market analysis tools. The content itself is very brief and embedded within a broader financial information portal.

    TradingView•7/9/26•
    Neutral

    Price to earnings forward of Enhabit, Inc – LS:A3DNM9

    This article provides financial information for Enhabit, Inc (LS:A3DNM9) on the TradingView platform. It shows that the market is currently closed with no trades, and displays a section for "Price to earnings forward" but without specific data in the provided snippet. The content primarily highlights navigation and footer information related to TradingView services and partners.

    TradingView•7/8/26•
    Neutral

    Enhabit, Inc Actuals & Estimates (LS:A3DNM9)

    This article provides financial actuals and estimates for Enhabit, Inc (LS:A3DNM9), including its stock price, forecast, historical performance, market capitalization, earnings, revenue, and EBITDA. It also details the company's employee count and dividend policy, offering a comprehensive overview for potential investors.

    TradingView•6/27/26•
    Neutral

    A3DNM9 Forecast — Price Target — Prediction for 2027

    This article provides a forecast, price target, and prediction for Enhabit, Inc. (A3DNM9) stock for 2027. It details analyst ratings, price targets, financial metrics such as EPS, revenue, market cap, and EBITDA, and answers frequently asked questions about the company's stock performance and future outlook.

    TradingView•6/27/26•
    Neutral

    Frequently Asked Questions About EHAB

    Does EHAB pay dividends?
    EHAB (EHAB) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In